◆ TICKERBASEOpen interactive view →
◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocksH › HTFL

Heartflow, Inc. Common Stock (HTFL) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · HEALTH INFORMATION SERVICES · DATA UPDATED 2026-08-23

Heartflow, Inc. Common Stock (HTFL) operates in the HEALTH INFORMATION SERVICES industry and is headquartered in San Francisco, United States with about 843 employees. Its market capitalization is roughly $4 billion. In the fiscal year ended 2025-12-31, HTFL reported $176M in revenue and ($117M) in net income.

HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases the United States and worldwide.

Interactive charts & full statements → Open the HTFL valuation workbench →

HTFL Revenue & Earnings History — Annual Income Statement

Income statementTTM → 2026-06-302025-12-312024-12-312023-12-31
Total Revenue$212M$176M$126M$87M
Gross Profit$170M$135M$94M$58M
Gross Margin %80.1%76.8%75.1%66.6%
Operating Income (EBIT)($73M)($64M)($61M)($73M)
Operating Margin %-34.3%-36.4%-48.7%-83.6%
Net Income($118M)($117M)($96M)($96M)
Net Margin %-55.8%-66.3%-76.6%-109.7%
EBITDA($108M)($93M)($65M)($63M)
Earnings Per Share (EPS)$-1.42$-1.37$-1.53$-1.50
Shares Outstanding (M)86M85M63M64M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

HTFL Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
Total Revenue$64M$53M$49M$46M$43M$37M$35M$33M
Gross Profit$53M$42M$39M$35M$33M$28M$26M$25M
Gross Margin %83.0%80.2%79.5%76.5%75.5%75.1%75.0%75.7%
Operating Income (EBIT)($18M)($22M)($18M)($15M)($14M)($18M)($16M)($15M)
Operating Margin %-27.9%-41.9%-36.1%-32.6%-31.6%-47.0%-45.9%-45.3%
Net Income($16M)($27M)($24M)($51M)($9M)($32M)($33M)($19M)
Net Margin %-24.6%-52.1%-49.6%-109.9%-21.2%-86.9%-94.3%-58.1%
EBITDA($16M)($25M)($22M)($45M)$0M($25M)($25M)($12M)
Earnings Per Share (EPS)$-0.18$-0.32$-0.29$-0.63$-0.11$-0.51$-0.52$-0.30
Shares Outstanding (M)86M86M85M81M81M64M63M64M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

HTFL Free Cash Flow History

Cash flowTTM → 2026-06-302025-12-312024-12-312023-12-31
Cash from Operations (CFO)($52M)($54M)($69M)($76M)
Capital Expenditures (CapEx)$7M$5M$4M$6M
Free Cash Flow (FCF)($59M)($59M)($73M)($83M)
FCF Margin %-27.9%-33.5%-58.3%-94.7%

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

HTFL Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
Cash from Operations (CFO)($9M)($30M)($11M)($3M)($27M)($13M)($14M)($10M)
Capital Expenditures (CapEx)$2M$2M$2M$1M$1M$1M$0M$1M
Free Cash Flow (FCF)($11M)($32M)($12M)($4M)($28M)($14M)($14M)($11M)
FCF Margin %-16.4%-60.8%-25.4%-9.1%-64.7%-38.4%-41.1%-34.3%

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

HTFL Balance Sheet History

Balance sheet2026-06-302025-12-312024-12-312023-12-31
Total Assets$344M$359M$119M$185M
Cash & Cash Equivalents$34M$45M$51M$123M
Total Liabilities$65M$59M$978M$963M
Total Debt (Short + Long-Term)$7M$6M$142M$139M
Total Shareholders' Equity$280M$301M($859M)($778M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive HTFL viewer.

Other Companies in HEALTH INFORMATION SERVICES

← HTELAll “H” companiesHTG →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.